Home » China’s SFDA Requests Recall of GSK Antibiotic Augmentin
China’s SFDA Requests Recall of GSK Antibiotic Augmentin
China’s State Food and Drug Administration (SFDA) has ordered a recall of GlaxoSmithKline’s (GSK) antibiotic Augmentin after tests showed the product contained traces of a plastics additive.
Drug GMP Report
Drug GMP Report
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May